Sökning: "Pseudomonas aeruginosa infection"
Visar resultat 21 - 25 av 33 avhandlingar innehållade orden Pseudomonas aeruginosa infection.
21. Regulation of bacterial adaptive behavior by the second messenger cyclic-di-GMP and host components
Sammanfattning : To optimize survival and growth, bacteria have evolved adaptive behaviors that respond to relevant environmental signals. A switch from the motile to the sessile lifestyle is probably the most ancient behavioral transition of microorganisms. LÄS MER
22. Studies on Staphylococcus epidermidis biofilm formation and the bacterial interaction with the human cathelicidin antimicrobial peptide LL-37
Sammanfattning : The long-term use of central venous catheters for delivering nutrients and drugs in preterm neonates has been related to nosocomial infections. The majority of late-onset sepsis in very preterm infants (... LÄS MER
23. Respiratory Tract Infections: Aspects of Aetiology, Virulence, and Communicable Disease Control
Sammanfattning : The paediatric nasopharyngeal flora is regarded as the largest reservoir for Streptococcus pneumoniae, and the carrier state is always antecedent to infection and a prerequisite for dispersion of these bacteria. Pneumococci are the predominant aetiology of bacterial respiratory tract infections and a major cause of morbidity and mortality, in the most severe cases due to invasive pneumococcal disease (IPD; mainly sepsis and meningitis). LÄS MER
24. Chemical attenuation of bacterial virulence : small molecule inhibitors of type III secretion
Sammanfattning : Despite the large arsenal of antibiotics available on the market, treatment of bacterial infections becomes more challenging in view of the fact that microbes develop resistance against existing drugs. There is an obvious need for novel drugs acting on both old and new targets in bacteria. LÄS MER
25. Quantifying effects of antimicrobial drug combinations by modelling and simulation
Sammanfattning : Antibiotic resistance is becoming an accelerating issue, both in the treatment of nosocomial infections and for public health in general. There is a pressing need for innovative methods to understand how available antibiotics could be combined to overcome and limit the emergence of resistance. LÄS MER